2-(4-chlorophenyl)-8-methylquinazolin-4-one | 1361458-50-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 2-(4-chlorophenyl)-8-methylquinazolin-4-one
• 英文别名: 2-(4-chlorophenyl)-8-methyl-3H-quinazolin-4-one
• CAS: 1361458-50-5
• 化学式: C₁₅H₁₁ClN₂O
• 分子量: 270.718
• InChiKey: GNYGUGSAEOIONU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.55
• 重原子数：
  19.0
• 可旋转键数：
  1.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  45.75
• 氢给体数：
  1.0
• 氢受体数：
  2.0

反应信息

• 作为产物：
  描述：

  在 吡啶 、 盐酸 、 ammonium hydroxide 、 sodium hydroxide 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 35.5h， 生成 2-(4-chlorophenyl)-8-methylquinazolin-4-one
  参考文献：
  名称：

  Design and Discovery of 2-Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases

  摘要：

  Tankyrases (TNKSs) are poly(ADP-ribose)polymerases (PARPs) that are overexpressed in several clinical cancers. They regulate elongation of telomeres, regulate the Writ system, and are essential for the function of the mitotic spindle. A set of 2-arylquinazolin-4-ones has been designed and identified as potent and selective TNKS inhibitors, some being more potent and selective than the lead inhibitor XAV939, with IC50 = 3 nM vs. TNKS-2. Methyl was preferred at the 8-position and modest bulk at the 4-position of the 2-phenyl group; electronic effects and H-bonding were irrelevant, but charge in the 4'-substituent must be avoided. Molecular modeling facilitated initial design of the compounds and rationalization of the SAR of binding into the nicotinamide-binding site of the target enzymes. These compounds have potential for further development into anticancer drugs.

  DOI：

  10.1021/ml400260b

文献信息

• Electrochemical synthesis of quinazolinone <i>via</i> I₂-catalyzed tandem oxidation in aqueous solution
  作者：Huiqing Hou、Xinhua Ma、Yingying Lin、Jin Lin、Weiming Sun、Lei Wang、Xiuzhi Xu、Fang Ke

  DOI：10.1039/d1ra02706a

  日期：——

  green and sustainable chemistry for their synthesis. Herein, using I2 in coordination with electrochemical synthesis induced a C–H oxidation reaction which is reported when using water as the environmentally friendly solvent to access a broad range of quinazolinones at room temperature. The reaction mechanism strongly showed that I2 cooperates electrochemically promoted the oxidation of alcohols, then

  开发在水性介质中使用生物相容性催化剂合成喹唑啉酮的方案将有助于解决使用绿色和可持续化学合成它们的困难。在此，使用 I 2与电化学合成配合会引起 C-H 氧化反应，据报道，当使用水作为环境友好溶剂在室温下获得广泛的喹唑啉酮时。反应机理有力地表明，I 2协同电化学促进醇的氧化，然后有效地将酰胺环化为各种喹唑啉酮。
• Electrochemically induced synthesis of quinazolinones <i>via</i> cathode hydration of <i>o</i>-aminobenzonitriles in aqueous solutions
  作者：Li Yang、Huiqing Hou、Lan Li、Jin Wang、Sunying Zhou、Mei Wu、Fang Ke

  DOI：10.1039/d0ob02286a

  日期：——

  for the synthesis of substituted quinazolinones from simple and readily available o-aminobenzonitriles and aldehydes in water has been accomplished. I2/base and water play an unprecedented and vital role in the reaction. By electrochemically catalysed hydrolysis of o-aminobenzonitriles, the synthesis of quinazolinones with benzaldehyde was first proposed. The synthetic utility of this method was demonstrated

  已经实现了从水中的简单且容易获得的邻氨基苯甲腈和醛类合成取代的喹唑啉酮类的有效且实用的无催化过渡金属的方法。I 2 /碱和水在反应中起着前所未有的重要作用。通过电化学催化邻氨基苯甲腈的水解，首次提出了与苯甲醛合成喹唑啉酮的方法。该方法的合成效用通过克级操作以及生物活性N-（2,5-二氯苯基）-6-（2,2,2-三氟乙氧基）蝶呤-4-胺的制备得到证明。简单，实用且对环境无害的喹唑啉酮形成。
• [EN] TANKYRASE INHIBITORS<br/>[FR] INHIBITEURS DE TANKYRASE
  申请人：UNIV BATH

  公开号：WO2014087165A1

  公开（公告）日：2014-06-12

  The present invention relates to a compound of formula I wherein X is C(R6) or N, Y is C or N, and ring A, ring B, R1 and R2 have the meanings defined herein, provided that when ring B is carbocyclic, X is C(R6); or a pharmaceutically acceptable salt or solvate thereof. The compounds are tankyrase-1 and tankyrase-2 inhibitors and are useful in the treatment of a number of conditions, including cancer.

  本发明涉及一种具有式I的化合物，其中X为C(R6)或N，Y为C或N，环A、环B、R1和R2具有本文中定义的含义，前提是当环B为碳环时，X为C(R6)；或其药学上可接受的盐或溶剂。这些化合物是坦克酶-1和坦克酶-2抑制剂，并可用于治疗多种疾病，包括癌症。
• Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases
  作者：Amit Nathubhai、Teemu Haikarainen、Penelope C. Hayward、Silvia Muñoz-Descalzo、Andrew S. Thompson、Matthew D. Lloyd、Lari Lehtiö、Michael D. Threadgill

  DOI：10.1016/j.ejmech.2016.04.041

  日期：2016.8

  Tankyrases (TNKSs), members of the PARP (Poly(ADP-ribose)polymerases) superfamily of enzymes, have gained interest as therapeutic drug targets, especially as they are involved in the regulation of Wnt signalling. A series of 2-arylquinazolin-4-ones with varying substituents at the 8-position was synthesised. An 8-methyl group (compared to 8-H, 8-OMe, 8-OH), together with a 4′-hydrophobic or electron-withdrawing

  Tankyrases (TNKSs) 是 PARP（聚（ADP-核糖）聚合酶）酶超家族的成员，作为治疗药物靶点引起了人们的兴趣，特别是因为它们参与 Wnt 信号传导的调节。合成了一系列在 8 位具有不同取代基的 2-芳基喹唑啉-4-酮。8-甲基（与 8-H、8-OMe、8-OH 相比）与 4'-疏水或吸电子基团一起对 TNKS 提供了最大的效力和选择性。所选化合物与 TNKS-2 的共晶结构表明，与 PARP-1/2 相比，TNKS-2 中 8 位附近的蛋白质更具疏水性，从而使选择性合理化。NAD +-结合位点包含容纳 2-芳基的疏水腔；在 TNKS-2 中，它有一条通往外部的隧道，但在 PARP-1 中空腔是封闭的。8-Methyl-2-(4-trifluoromethylphenyl)quinazolin-4-one 被确定为 TNKSs 和 Wnt 信号传导的有效和选择性抑制剂。这种
• Design and Discovery of 2-Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases
  作者：Amit Nathubhai、Pauline J. Wood、Matthew D. Lloyd、Andrew S. Thompson、Michael D. Threadgill

  DOI：10.1021/ml400260b

  日期：2013.12.12

  Tankyrases (TNKSs) are poly(ADP-ribose)polymerases (PARPs) that are overexpressed in several clinical cancers. They regulate elongation of telomeres, regulate the Writ system, and are essential for the function of the mitotic spindle. A set of 2-arylquinazolin-4-ones has been designed and identified as potent and selective TNKS inhibitors, some being more potent and selective than the lead inhibitor XAV939, with IC50 = 3 nM vs. TNKS-2. Methyl was preferred at the 8-position and modest bulk at the 4-position of the 2-phenyl group; electronic effects and H-bonding were irrelevant, but charge in the 4'-substituent must be avoided. Molecular modeling facilitated initial design of the compounds and rationalization of the SAR of binding into the nicotinamide-binding site of the target enzymes. These compounds have potential for further development into anticancer drugs.